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S U M M A R Y
Objectives: To estimate the prevalence of and risk factors for latent tuberculosis infection (LTBI) among
contacts of index patients with tuberculosis (TB) with a prior history of active TB disease and TB
treatment (retreatment cases).
Methods: A cross-sectional population-based study was conducted using data from the national TB
contact surveillance program in the country of Georgia. Contacts of retreatment cases were investigated
and tuberculin skin testing was offered. Bivariate and multivariable analyses were performed to
calculate odds ratios (OR) and 95% conﬁdence intervals for risk of LTBI among contacts.
Results: The prevalence of LTBI was signiﬁcantly higher among contacts whose index TB patient had had
a prior unfavorable treatment outcome compared to those who had had a favorable outcome (OR 3.14).
Contacts whose index TB case had previously failed therapy (OR 6.43), was lost to follow-up (OR 5.63), or
had completed treatment (OR 3.33) had a signiﬁcantly higher prevalence of LTBI compared to contacts of
previously cured TB cases.
Conclusions: Among contacts of active TB retreatment cases, the risk of LTBI was related to the outcome
of the index case’s previous TB treatment. Efforts aimed at reducing treatment loss to follow-up should
be emphasized to enhance TB control efforts and may also decrease LTBI and active TB among contacts.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tuberculosis (TB) remains a serious global public health
problem, including in the country of Georgia. In 2014, the World
Health Organization (WHO) reported the incidence rate of TB in
Georgia to be 106 cases per 100 000 persons.1 Georgia has high
rates of multidrug-resistant (MDR) TB. Close contacts of persons
with active TB disease are at increased risk of latent TB infection
(LTBI) and active TB disease.2 Contact investigation of close
contacts is a recommended control strategy for active TB case
ﬁnding and for detecting individuals with LTBI who are at
increased risk of progressing to active TB disease.3–5* Corresponding author. Tel.: +995 598 552655.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contact investigations are commonly conducted in high-
income, low TB incidence countries, but are generally not part
of routine TB control efforts in most low- and middle-income
countries (LMIC). Nonetheless, contact investigations are recom-
mended by the WHO in LMIC where the burden of TB disease is
greatest.3 In 2012, the National Center for Disease Control and
Public Health (NCDC) initiated a nationwide TB contact investiga-
tion program in the country of Georgia. Using data from this
program, it was aimed to estimate the prevalence of and risk
factors for LTBI among contacts of index patients with a prior
history of treatment for active TB (retreatment cases).
2. Methods
This cross-sectional study was conducted using surveillance
data from the entire country of Georgia. Only the close contacts ofciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Association of index case previous TB treatment outcome and the prevalence of LTBI
among their contacts
Outcome of
index case,
previous TB
treatment
Contacts with
LTBI (%)
n = 46
Contacts
without
LTBI (%)
n = 93
OR (95% CI) p-Value
Cured 8 (15.1) 45 (84.9) 1.00 <0.01
Completed 16 (37.2) 27 (62.8) 3.33 (1.26–8.82) 0.01
Lost to follow-up 14 (50.0) 14 (50.0) 5.63 (1.96–16.16) <0.01
Failure 8 (53.3) 7 (46.7) 6.43 (1.81–22.72) <0.01
TB, tuberculosis; LTBI, latent tuberculosis infection; OR, odds ratio; CI, conﬁdence
interval.
Table 2
Prevalence of LTBI among contacts of index TB retreatment cases based on the index
patient’s prior TB treatment outcome
Characteristic aOR
(n = 131)
95% CI
Outcome completed vs. cured 3.25 1.20–8.78
Outcome lost to follow-up vs. cured 3.67 1.13–11.89
Outcome failure vs. cured 7.75 2.05–29.32
Household vs. non-household contact 3.03 0.76–12.08
Male contacts vs. female contacts 1.57 0.69–3.55
LTBI, latent tuberculosis infection; TB, tuberculosis; aOR, adjusted odds ratio (the
model included all variables in the table); CI, conﬁdence interval.
D. Baliashvili et al. / International Journal of Infectious Diseases 43 (2016) 49–5050retreatment TB cases (index cases) who were sputum AFB smear-
positive at the time of diagnosis as a retreatment case, identiﬁed
between April and December 2012, were included. Epidemiolo-
gists afﬁliated with the NCDC interviewed each index retreatment
case to determine close contacts, deﬁned as members of the same
household and non-household contacts who had daily contact
with the index patient. Contacts were offered tuberculin skin
testing; if they accepted, a tuberculin skin test (TST) was carried
out using the Mantoux method,6 with 0.1 ml tuberculin. An
induration of 10 mm was deﬁned as a positive TST. LTBI was
deﬁned as having a positive TST (the ﬁrst step of investigation)
without symptoms of active TB disease. Contacts with a positive
TST were referred to a TB physician for further evaluation, but were
not followed up as part of this study.
Analyses were performed using SAS version 9.3 software (SAS
Institute Inc., Cary, NC, USA). Bivariate analyses and multivariable
logistic regression analyses were used to calculate odds ratios (OR)
and 95% conﬁdence intervals (95% CI) for the risk of LTBI among
contacts. The primary exposure of interest was the index patient’s
outcome of previous TB episode: cure, completion, loss to follow-
up, or failure. Treatment outcomes were deﬁned based on WHO
deﬁnitions.7 Model building and selection was based on the
purposeful selection of covariates strategy.8 A two-sided p-value of
<0.05 was considered statistically signiﬁcant for all analyses. The
study was approved by the institutional review boards of Emory
University and the Georgian NCDC.
3. Results
Among 583 close contacts of index patients with active TB and a
prior history of TB (i.e., retreatment cases), 139 (24%) received a
TST and were included in this analysis. The overall prevalence of
LTBI among these contacts was 33% (46/139). The prevalence of
LTBI was signiﬁcantly higher among those contacts whose index TB
case had had an unfavorable treatment outcome (failed or lost to
follow-up) during their prior treatment episode compared to those
whose index patient had had a favorable outcome (cured or
completed) (OR 3.14, 95% CI 1.48–6.70). Further analysis showed
that contacts whose index TB case had failed, was lost to follow-up,
or completed treatment had a signiﬁcantly higher prevalence of
LTBI compared to contacts of TB cases who had previously been
cured (Table 1).
On multivariable analysis, controlling for sex of the contact and
type of contact, independent risk factors for LTBI included being a
contact of an index TB case who had completed treatment
(adjusted OR (aOR) 3.25, 95% CI 1.20–8.78), was lost to follow-up
(aOR 3.67, 95% CI 1.13–11.89), or had failed treatment (aOR 7.75,
95% CI 2.05–29.32), as compared to contacts of TB cases who had
had a prior outcome of cure (Table 2).4. Discussion
This investigation appears to be the ﬁrst to report that
contacts of index patients with active TB disease who are
retreatment cases have a signiﬁcantly higher risk of having LTBI
based on a prior unfavorable treatment outcome in the index TB
case. In this study, the risk of LTBI appeared to be dose-
dependent, based on the outcome of the index TB case’s previous
TB treatment. This novel result highlights the importance of
completing TB treatment regimens and curing patients, especial-
ly in countries like Georgia, where the loss to follow-up rate
among MDR-TB patients is high.9 Index cases whose initial
treatment regimen is not successful are likely to remain
infectious for prolonged periods of time, resulting in a greater
risk of transmission of Mycobacterium tuberculosis among their
contacts. Therefore, efforts aimed at reducing treatment loss to
follow-up should enhance TB control efforts and may also
decrease LTBI and active TB among contacts.
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